Springer Medicine

Springer Medicine

@springermedicine.com

Trustworthy, tailored, cutting-edge content for medical professionals who want to deliver the best possible care. Learn more here: springermedicine.com

187 followers89 following1.4K posts

Pinned

Keep up to date with the latest findings, expert insights, and clinical updates from across the spectrum of digestive health with our #UEGWeek2026 congress hub. Unlock your free access here 👉️ buff.ly/adjbbtY #GISky #MedSky

#Obesity may worsen #migraine frequency, severity, and disability. Explore shared biological mechanisms and evolving management approaches, from lifestyle interventions to CGRP-targeted therapies and GLP-1 receptor agonists. 👉️ buff.ly/CzzlKJf #NeuroSky

buff.lyMigraine and Obesity: From Shared Mechanisms to Therapeutic StrategiesObesity may worsen migraine frequency, severity, and disability. Explore shared biological mechanisms and evolving management approaches, from lifestyle interventions to CGRP-targeted therapies and…

#MedCase - Chemical injury from contact lenses accidentally soaked in makeup remover triggered a sterile corneal infiltrate mimicking infectious #keratitis. Which features distinguish sterile from infectious infiltrates? Find out here 👉️ buff.ly/S4WURXz #EyeSky

buff.lySterile peripheral corneal infiltration mimicking infectious keratitis following chemical injury: a case reportChemical injury from contact lenses accidentally soaked in makeup remover triggered a sterile corneal infiltrate mimicking infectious keratitis. Which features distinguish sterile from infectious…

Charcot neuro-osteoarthropathy is a limb-threatening yet under-recognized complication of #diabetes. Gaps in understanding of susceptibility, pathogenesis, diagnosis, remission, and treatment need to be addressed to improve outcomes. 👉️ buff.ly/b4PGIxb #NeuroSky

buff.lyCharcot neuro-osteoarthropathy in diabetes: comprehensive review from missed diagnosis to durable long-term remissionCNO is a limb-threatening yet under-recognized complication of diabetes. Gaps in understanding of susceptibility, pathogenesis, diagnosis, remission, and treatment need to be addressed to improve…

From #UEGWeek2026 - Primary percutaneous stenting may be a better option than endoscopic biliary drainage for managing unresectable malignant hilar biliary obstruction. Full story 👉️ buff.ly/HrS8xea #GISky#MedNews

springermedicine.comTESLA study backs primary percutaneous stenting for hilar biliary obstructionPrimary percutaneous stenting may be a better option than endoscopic biliary drainage for managing unresectable malignant hilar biliary obstruction.

Take a deep dive into the rapidly evolving world of #CancerVaccines with Dr. Elias Sayour as he discusses what it means to vaccinate against cancer, where vaccines show the most promise, and what the challenges of making such vaccines are. 👉️ buff.ly/akcAJXi #ESMO2026 #OncSky

Female survivors of childhood cancer carry unique & dynamic CV risks across their lifetimes, requiring lifelong CV surveillance that incorporates prior oncologic exposures, thrombotic history, & reproductive health alongside traditional risk factors. 👉️ buff.ly/m3jPUed #CardioSky #OncSky

buff.lyFemale Cardiovascular Health After Childhood CancerFemale survivors of childhood cancer carry unique and dynamic CV risks across their lifetimes, requiring lifelong CV surveillance that incorporates prior oncologic exposures, thrombotic history, and…

From #UEGWeek2026 - Patients with moderately to severely active ulcerative colitis are significantly more likely to achieve clinical remission after 12 weeks of icotrokinra than placebo. Full story 👉️ buff.ly/55h7HNB #GISky #MedNews

springermedicine.comOral IL-23 receptor inhibition approach feasible for moderately to severely active UCPatients with moderately to severely active ulcerative colitis are significantly more likely to achieve clinical remission after 12 weeks of icotrokinra than placebo.

Are you at #ESMO26? Head to Booth 1035 to claim your free access to congress coverage, expert-led webinars and podcasts, and more 🎯

Springer Health+@springerhealthplus.com

We're here at #ESMO26! Visit us at Booth 1035 to find out more about @springermedicine.com, our free medical education platform, as well as our @ime.springerhealthplus.com programs across oncology 🚀

#MedCase - Acute-onset #headache may signal reversible cerebral vasoconstriction syndrome, even without early imaging abnormalities, particularly when postpartum patients develop new focal neurological deficits, as this case highlights. 👉️ buff.ly/hyqXktx #NeuroSky

springermedicine.comA postpartum woman with recurrent headaches and transient neurological deficits: a case reportAcute-onset headache may signal reversible cerebral vasoconstriction syndrome, even without early imaging abnormalities, particularly when postpartum patients develop new focal neurological deficits.

From #EURETINA2026 - Researchers have shown a five-fold reduction in the risk for contralateral retinal detachment in patients with #SticklerSyndrome using prophylactic laser photocoagulation. Full story 👉️ buff.ly/S8O0xYi #MedNews

buff.lyReal-world data support laser photocoagulation to reduce contralateral retinal detachment riskResearchers have shown a five-fold reduction in the risk for contralateral retinal detachment in patients with Stickler syndrome using prophylactic laser photocoagulation.

From #EURETINA2026 - Prof. Aniruddha Agarwal discusses how multimodal imaging can be integrated into diagnostic workflows for noninfectious posterior uveitis to improve detection, disease monitoring, and treatment decision-making. Full interview 👉️ buff.ly/KVG3R2c #EyeSky

#MedCase - Sarcoidosis-like reaction involving the skin and sclera after long-term tocilizumab therapy for giant cell arteritis. Withdrawal of tocilizumab and minimal glucocorticoid escalation resulted in complete resolution. Examine the case 👉️ buff.ly/iQQRjZd #RheumSky

springermedicine.comSarcoidosis-like reaction associated with tocilizumab in a patient with giant cell arteritis: a case based reviewSarcoidosis-like reaction involving the skin and sclera after long-term tocilizumab therapy for giant cell arteritis. Withdrawal of tocilizumab and minimal glucocorticoid escalation resulted in…

From #EASD2026 - Diabetes management may be aided by #GLP1 receptor agonist use in young people with type 2 diabetes, and a very-low-carbohydrate diet in children with type 1 diabetes. Full story 👉️ buff.ly/qI4KxNr #PediatricDiabetes #MedNews

From #EURETINA2026 - AAVB-081, a dual adeno-associated virus gene therapy for the treatment of Usher syndrome type 1B retinitis pigmentosa, has shown favorable safety and early signs of visual improvement. Full story 👉️ buff.ly/9M8bqej #MedNews #EyeSky

buff.lyAAVB-081 gene therapy shows early promise for retinitis pigmentosa in Usher syndrome type 1BAAVB-081, a dual adeno-associated virus gene therapy for the treatment of Usher syndrome type 1B retinitis pigmentosa, has shown favorable safety and early signs of visual improvement.

From #EASD2026 - Weekly treatment with survodutide, a GLP-1 receptor/glucagon receptor dual agonist, significantly reduces bodyweight and glycated hemoglobin in people with obesity and type 2 diabetes. Full story 👉️ buff.ly/wcG5bue #T2D #MedNews

buff.lySurvodutide offers clinically significant bodyweight reductions in obesity with type 2 diabetesWeekly treatment with survodutide, a GLP-1 receptor/glucagon receptor dual agonist, significantly reduces bodyweight and glycated hemoglobin in people with obesity and type 2 diabetes.

From #EURETINA2026 - Persistent fluid in people receiving treatment for diabetic macular edema can have a detrimental effect on outer membrane structure over time that can ultimately lead to irreversible vision loss. Full story 👉️ buff.ly/LyNZn08 #MedNews

buff.lyEarly fluid control in DME may preserve long-term visual acuityPersistent fluid in people receiving treatment for diabetic macular edema can have a detrimental effect on outer membrane structure over time that can ultimately lead to irreversible vision loss.

From #EURETINA2026 - Prof. Peter Stalmans talks about how robotic platforms are transforming ophthalmic surgery, making ultra-precise maneuvers and novel techniques a clinical reality. Watch the full interview 👉️ buff.ly/kqWRzDw #EyeSky #EyeSurgery

From #EASD2026 - Dr. Maria Houborg Petersen reports that women who have experienced gestational diabetes develop type 2 diabetes earlier than women without a history of gestational disease. Watch the full interview 👉️ buff.ly/XScMgeZ #Diabetes #WomensHealth

This review critically evaluates emerging evidence on the onset or exacerbation of autoimmune thyroid eye disease following SARS-CoV-2 vaccination and considers unresolved controversies and clinically relevant implications. 👉️ buff.ly/MUfpmGY #EyeSky #GravesDisease

springermedicine.comCOVID-19 vaccine-associated autoimmune thyroid eye disease: Graves’ orbitopathyThis review critically evaluates emerging evidence on the onset or exacerbation of autoimmune thyroid eye disease following SARS-CoV-2 vaccination and considers unresolved controversies and…

From #EASD2026 - SMARTEST indicates that dapagliflozin and metformin offer similar protection against the development of cardiovascular and renal complications for people with early-stage type 2 diabetes. Full story 👉️ buff.ly/2IrXajI #CardioSky #MedNews

buff.lyNo early type 2 diabetes superiority for dapagliflozin or metforminSMARTEST indicates that dapagliflozin and metformin offer similar protection against the development of cardiovascular and renal complications for people with early-stage type 2 diabetes.

Heading to #UEGWeek2026? Looking for something to listen to while travelling? Catch up on our conversation with Prof. Edoardo Savarino as he looks at how the joint UEG and ESNM #dysphagia guidelines remove uncertainty about its diagnostic work-up and management. 👉️ buff.ly/NukVwtG #GISky

From #EASD2026 - The ADA and EASD have updated their consensus statement on the management of #T2D in nonpregnant adults in the USA and Europe to include a holistic approach to reduce the risk for the multiple associated conditions in this population. 👉️ buff.ly/dDFThG2 #MedNews

buff.lyUpdated ADA/EASD type 2 diabetes management consensus emphasizes holistic approachThe ADA and EASD have updated their consensus statement on the management of type 2 diabetes in nonpregnant adults in the USA and Europe to include a holistic approach to reduce the risk for the…

From #EURETINA2026 - Two investigational gene therapies for neovascular age-related macular degeneration show favorable safety, maintained visual acuity, and a reduced treatment burden compared with standard anti-VEGF treatment. Full story 👉️ buff.ly/dMvwh71 #MedNews #EyeSky

buff.lyGene therapies maintain visual acuity in wet AMD with less treatment burdenTwo investigational gene therapies for neovascular age-related macular degeneration show favorable safety, maintained visual acuity, and a reduced treatment burden compared with standard anti-VEGF…

From #EASD2026 - The EASD Clinical Practice Guideline for managing #DiabetesDistress has been published. Listen to the update from Profs Richard Holt and Jane Speight on how the draft guideline evolved after consultation 👉️ buff.ly/I3YRib6 #Diabetes

From #EURETINA2026 - The bioerodible EYP-1901, an intravitreal insert that delivers vorolanib, has failed to show noninferiority to aflibercept 2 mg in patients with wet AMD despite providing strong anatomic control. 👉️ buff.ly/FiihEys #MedNews

buff.lyIntravitreal insert misses noninferiority endpoint vs aflibercept in wet AMDThe bioerodible EYP-1901, an intravitreal insert that delivers vorolanib, has failed to show noninferiority to aflibercept 2 mg in patients with wet age-related macular degeneration despite providing…

From #EASD2026 - Prof. Elif Ekinci shares the efficacy and safety findings from TRIUMPH-2, a phase 3 trial of the GIP, GLP-1, and glucagon receptor agonist #retatrutide in patients with type 2 diabetes and obesity. Watch the full interview 👉️ buff.ly/sivRg5m #DiabetesCare

From #EURETINA2026 - Vision restoration with the PRIMA subretinal neurostimulation system persists in people with geographic atrophy due to age-related macular degeneration for at least 36 months. Full story 👉️ buff.ly/dqq8nyF #MedNews #EyeSky

buff.lySubretinal neurostimulation system shows sustained vision restoration for AMDVision restoration with the PRIMA subretinal neurostimulation system persists in people with geographic atrophy due to age-related macular degeneration for at least 36 months.

How do evidence-based recommendations for pharmacologic treatment of #migraine translate into clinical practice? Prof. Simona Sacco discusses how to navigate the expanding treatment landscape. Full episode out now 👉️ buff.ly/DkmlzD4 #NeuroSky #MedSky